We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
- Authors
Davidson, D F; Grosset, K; Grosset, D
- Abstract
L-dopa is an important antiparkinsonian drug. It is a precursor of dopamine and the other catecholamines. Potentially, administration of L-dopa could lead to increased urinary excretion of catecholamines and their metabolites to abnormal amounts. The current study aimed to determine these excretions in patients with Parkinson's disease (PD) receiving L-dopa compared with suitable controls. This is the first assessment of the effect of exogenous administration of L-dopa on urinary free metadrenalines.
- Publication
Annals of clinical biochemistry, 2007, Vol 44, Issue Pt 4, p364
- ISSN
0004-5632
- Publication type
Journal Article
- DOI
10.1258/000456307780945705